Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories board meetings
113 filed, newest first. Page 2 of 3.
May 2019
Feb 2019
2 Feb · Board meeting
2 Feb · Board meeting
Jan 2019
Oct 2018
Jul 2018
May 2018
Jan 2018
Oct 2017
31 Oct · Board meeting
Jul 2017
Jun 2017
May 2017
Jan 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Feb 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Jan 2015
Oct 2014
22 Oct · Board meeting
To consider and approve, inter-alia, the un-audited financial results for the quarter and half-year ended September 30, 2014.
Jul 2014
May 2014
Jan 2014
Oct 2013
28 Oct · Board meeting
To consider and approve, inter-alia, the un-audited financial results for the half year and quarter ended September 30, 2013.
Jul 2013
24 Jul · Board meeting
To consider and approve, inter-alia, the un-audited financial results for the first quarter ended June 30, 2013.
May 2013
11 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2013 and to recommend Dividend on Equity Shares for the year ended March 31, 2013, if any.
Jan 2013
23 Jan · Board meeting
To consider and approve ,inter alia , the un-audited financial results for the third quarter ended December 31, 2012.
Oct 2012
19 Oct · Board meeting
To consider and approve, inter-alia, the un-audited financial results for the second quarter ended September 30, 2012.
Jul 2012
24 Jul · Board meeting
Inter-alia, to consider and approve the unaudited financial results for the first quarter ended June 30, 2012.
May 2012
4 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend Dividend on Equity Shares for the year ended March 31, 2012, if any.
Jan 2012
18 Jan · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2011.
Oct 2011
21 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2011.
Jul 2011
26 Jul · Board meeting
Inter-alia, to consider and approve the un-audited financial results for the quarter ended June 30, 2011.
May 2011
6 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2011 and to recommend Dividend on Equity Shares for the Year ended March 31, 2011, if any.
Jan 2011
22 Jan · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2010.
Oct 2010
28 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2010.
Jul 2010
30 Jul · Board meeting
Inter-alia, to consider and approve the un-audited financial results for the quarter ended June 30, 2010.
May 2010
10 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2010 and to recommend Dividend on Equity Shares for the Year ended March 31, 2010.
Jan 2010
18 Jan · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the third quarter ended December 31, 2009.
Oct 2009
16 Oct · Board meeting
Inter-alia, to consider and take on record the un-audited financial results for the second quarter ended September 30, 2009.
Jul 2009
21 Jul · Board meeting
Meeting on 31 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
27 May · Board meeting
Inter-alia, to consider and approve the audited financial results for the year ended March 31, 2009 and to recommend Dividend on Equity Shares for the year ended March 31, 2009, if any.
Jan 2009
15 Jan · Board meeting
Meeting on 24 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”